Medtronic plc (MDT) — Fair Value Analysis
Base-case fair value (P50): $83.32 · Current price: $91.27 · Verdict: Fairly Valued
The Verdict on MDT
Medtronic (MDT), a healthcare sector stalwart, currently trades at $91.27. Our Monte Carlo simulations, which model thousands of future scenarios for the company, establish a median fair value (P50) of $83.32. This indicates that MDT is trading at a premium to its calculated intrinsic value, specifically representing a -8.7% gap. Despite this difference, our overall verdict classifies MDT as "Fairly Valued" based on the distribution of potential outcomes from our modeling, suggesting that while downside exists, it is not sufficiently compelling to label it "overvalued" outright, considering the breadth of possible future states.
How MDT stacks up against Healthcare
While Medtronic operates within the resilient Healthcare sector, its operational and financial health is currently assessed as "weak" in our quality tier ranking. This quality tier indicates that MDT may face more headwinds or possess less financial flexibility compared to stronger peers within the sector. The current price of $91.27 relative to the P50 fair value of $83.32 reflects this underlying operational context. Investors should weigh the premium trading at $91.27 against the company’s quality tier and the -8.7% discrepancy from our median fair value estimate.
What this means for investors
For investors considering MDT, the analysis suggests a stock trading above its median fair value. The -8.7% against a $83.32 target, when the current price is $91.27, points to a negative return potential to the median intrinsic value. Given MDT's "weak" quality tier, investors should approach the current valuation with caution. While our "Fairly Valued" verdict encompasses a range of potential outcomes, the current premium suggests that the upside in a bull case scenario might be more limited, while a downside scenario could see prices move closer to or below the $83.32 mark. Sign up for FairCurve to see the full bear/bull distribution and track MDT's fair value as new fundamentals are released.
Frequently Asked Questions
Is MDT overvalued or undervalued right now?
Based on our Monte Carlo simulations, Medtronic (MDT) is currently trading at $91.27, which is above its median fair value (P50) of $83.32.
What is the bear case and bull case for MDT?
The full Monte Carlo distribution, including specific bear (P10) and bull (P90) target prices, along with the probability of upside, is available with a free FairCurve account. We do not provide specific dollar values here.
How does FairCurve calculate MDT's fair value?
FairCurve calculates MDT's fair value using sophisticated Monte Carlo simulations, running thousands of forward-looking scenarios to determine a probability-weighted intrinsic value distribution.
How can I track MDT's fair value as it changes?
You can add MDT to a free FairCurve watchlist to receive daily fair-value updates and instant re-valuation alerts whenever new earnings reports or other significant fundamentals are released.